Bharat Immunologicals (India) Risk Analysis And Volatility

BIBCL -- India Stock  

INR 8.83  0.33  3.88%

Macroaxis considers Bharat Immunologicals very risky given 2 months investment horizon. Bharat Immunologicals secures Sharpe Ratio (or Efficiency) of 0.0817 which signifies that the organization had 0.0817% of return per unit of standard deviation over the last 2 months. Our philosophy in foreseeing volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. By analyzing Bharat Immunologicals technical indicators you can presently evaluate if the expected return of 0.5047% is justified by implied risk. Please makes use of Bharat Immunologicals Mean Deviation of 3.18 and Risk Adjusted Performance of (0.06) to double-check if our risk estimates are consistent with your expectations.

60 Days Market Risk

Very risky

Chance of Distress in 24 months

Below average

60 Days Economic Sensitivity

Moves indifferently to market moves
Horizon     30 Days    Login   to change

Bharat Immunologicals Market Sensitivity

As returns on market increase, returns on owning Bharat Immunologicals are expected to decrease at a much smaller rate. During bear market, Bharat Immunologicals is likely to outperform the market.
2 Months Beta |Analyze Bharat Immunologicals Demand Trend
Check current 30 days Bharat Immunologicals correlation with market (DOW)
β = -0.0335

Bharat Immunologicals Central Daily Price Deviation

Bharat Immunologicals Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of thirty-nine. Bharat Immunologicals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input. View also all equity analysis or get more info about average price price transform indicator.

Bharat Immunologicals Projected Return Density Against Market

Assuming 30 trading days horizon, Bharat Immunologicals Biologicals Corp Ltd has beta of -0.0335 . This suggests as returns on benchmark increase, returns on holding Bharat Immunologicals are expected to decrease at a much smaller rate. During bear market, however, Bharat Immunologicals Biologicals Corp Ltd is likely to outperform the market. Additionally, The company has a negative alpha implying that the risk taken by holding this equity is not justified. Bharat Immunologicals is significantly underperforming DOW.
 Predicted Return Density 
      Returns 
Assuming 30 trading days horizon, the coefficient of variation of Bharat Immunologicals is 1224.69. The daily returns are destributed with a variance of 38.2 and standard deviation of 6.18. The mean deviation of Bharat Immunologicals Biologicals Corp Ltd is currently at 3.47. For similar time horizon, the selected benchmark (DOW) has volatility of 0.65
α
Alpha over DOW
=0.55
β
Beta against DOW=0.03
σ
Overall volatility
=6.18
Ir
Information ratio =0.12

Bharat Immunologicals Return Volatility

the company accepts 6.1806% volatility on return distribution over the 30 days horizon. the entity inherits 0.5908% risk (volatility on return distribution) over the 30 days horizon.
 Performance (%) 
      Timeline 

Bharat Immunologicals Investment Opportunity

Bharat Immunologicals Biologicals Corp Ltd has a volatility of 6.18 and is 10.47 times more volatile than DOW. 55% of all equities and portfolios are less risky than Bharat Immunologicals. Compared to the overall equity markets, volatility of historical daily returns of Bharat Immunologicals Biologicals Corp Ltd is higher than 55 (%) of all global equities and portfolios over the last 30 days.

Bharat Immunologicals Current Risk Indicators

Bharat Immunologicals Suggested Diversification Pairs

Check also Trending Equities. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
Search macroaxis.com